Current Status and Future Prospects of Genome-Scale Metabolic Modeling to Optimize the Use of Mesenchymal Stem Cells in Regenerative Medicine.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2020-03-31
Metadata
Show full item recordCitation
Sigmarsdóttir Þ, McGarrity S, Rolfsson Ó, Yurkovich JT, Sigurjónsson ÓE. Current Status and Future Prospects of Genome-Scale Metabolic Modeling to Optimize the Use of Mesenchymal Stem Cells in Regenerative Medicine. Front Bioeng Biotechnol. 2020;8:239. Published 2020 Mar 31. doi:10.3389/fbioe.2020.00239Abstract
Mesenchymal stem cells are a promising source for externally grown tissue replacements and patient-specific immunomodulatory treatments. This promise has not yet been fulfilled in part due to production scaling issues and the need to maintain the correct phenotype after re-implantation. One aspect of extracorporeal growth that may be manipulated to optimize cell growth and differentiation is metabolism. The metabolism of MSCs changes during and in response to differentiation and immunomodulatory changes. MSC metabolism may be linked to functional differences but how this occurs and influences MSC function remains unclear. Understanding how MSC metabolism relates to cell function is however important as metabolite availability and environmental circumstances in the body may affect the success of implantation. Genome-scale constraint based metabolic modeling can be used as a tool to fill gaps in knowledge of MSC metabolism, acting as a framework to integrate and understand various data types (e.g., genomic, transcriptomic and metabolomic). These approaches have long been used to optimize the growth and productivity of bacterial production systems and are being increasingly used to provide insights into human health research. Production of tissue for implantation using MSCs requires both optimized production of cell mass and the understanding of the patient and phenotype specific metabolic situation. This review considers the current knowledge of MSC metabolism and how it may be optimized along with the current and future uses of genome scale constraint based metabolic modeling to further this aim.Description
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAdditional Links
https://www.frontiersin.org/articles/10.3389/fbioe.2020.00239/fullhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136564/
Rights
Copyright © 2020 Sigmarsdóttir, McGarrity, Rolfsson, Yurkovich and Sigurjónsson.ae974a485f413a2113503eed53cd6c53
10.3389/fbioe.2020.00239
Scopus Count
Collections
Related articles
- From "Bench to Bedside": Current Advancement on Large-Scale Production of Mesenchymal Stem Cells.
- Authors: Bunpetch V, Wu H, Zhang S, Ouyang H
- Issue date: 2017 Nov 15
- Computational Modeling of Human Metabolism and Its Application to Systems Biomedicine.
- Authors: Aurich MK, Thiele I
- Issue date: 2016
- Applications of a metabolic network model of mesenchymal stem cells for controlling cell proliferation and differentiation.
- Authors: Fouladiha H, Marashi SA, Shokrgozar MA, Farokhi M, Atashi A
- Issue date: 2018 Feb
- Towards Personalized Regenerative Cell Therapy: Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
- Authors: Lin L, Bolund L, Luo Y
- Issue date: 2016
- Strategies for MSC expansion and MSC-based microtissue for bone regeneration.
- Authors: Bunpetch V, Zhang ZY, Zhang X, Han S, Zongyou P, Wu H, Hong-Wei O
- Issue date: 2019 Mar